Viral Infection and Lung Cancer Immunotherapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34434887/

Immunotherapy with immune checkpoint inhibitors (mainly anti-PD1 and anti-PDL1 monoclonal antibodies) became a standard of care in non-small cell lung cancer (NSCLC) patients. Most of the clinical trials excluded patients with hepatitis B (HBV), hepatis C (HCV), and human immunodeficiency virus (HIV ...